Skip to main content
OpenTrials
Completed

NCT Number: NCT01906086

Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among Adults

The aim of this randomized cross-over study was to determine the effects of legume consumption on adiponectin and inflammatory factors among first degree relatives of diabetic patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

30 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Isfahan University of Medical Sciences

Isfahan, Iran

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age more than 30 years
  • no history of chronic diseases
  • no use of blood glucose lowering drugs

Exclusion criteria

  • do not use recommended amounts of legumes
  • incidence of chronic diseases during the study
  • to start use of blood glucose lowering drugs

Treatment and study plan

Nutritional intervention

Other

life style intervention

Other

Primary outcomes

  1. high sensitive C reactive protein (mg/l)

    Time frame: 14 weeks

    amounts of hs-CRP

Secondary outcomes

  1. Interleukin-6 (pg/ml)

    Time frame: 14 weeks

    amounts of IL-6

  2. Tumor necrosis factor-α (pg/ml)

    Time frame: 14 weeks

    amounts of TNF-α

  3. Adiponectin (ng/ml)

    Time frame: 14 weeks

    amounts of adiponectin

Sponsors and collaborators

Lead sponsor

Isfahan University of Medical Sciences

Other

Registry information

Official study title

Effects of Legume Consumption on Adiponectin and Inflammatory Markers Among First Degree Relatives of Diabetic Patients

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Jul 23, 2013
Registry last updated
May 20, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.